| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S13277-015-4057-Z |
| P698 | PubMed publication ID | 26361956 |
| P2093 | author name string | Lei Gao | |
| Shuo Zhang | |||
| Ting Wang | |||
| Tian Yang | |||
| Mingwei Chen | |||
| Hui Ren | |||
| Tianjun Chen | |||
| Yiqian Liang | |||
| Asmitananda Thakur | |||
| P2860 | cites work | S100 family members and trypsinogens are predictors of distant metastasis and survival in early-stage non-small cell lung cancer | Q24301412 |
| Repression of the candidate tumor suppressor gene S100A2 in breast cancer is mediated by site-specific hypermethylation | Q24313442 | ||
| Intracellular and extracellular roles of S100 proteins | Q28184555 | ||
| S100A9/S100A8: Myeloid representatives of the S100 protein family as prominent players in innate immunity | Q28184564 | ||
| Differential expression of S100 protein subtypes in malignant melanoma, and benign and malignant peripheral nerve sheath tumors | Q28283566 | ||
| Cancer statistics, 2004 | Q29620739 | ||
| S100A2-S100P expression profile and diagnosis of non-small cell lung carcinoma: impairment by advanced tumour stages and neoadjuvant chemotherapy. | Q30319781 | ||
| Colon-derived liver metastasis, colorectal carcinoma, and hepatocellular carcinoma can be discriminated by the Ca(2+)-binding proteins S100A6 and S100A11 | Q33388693 | ||
| Mapping the zinc ligands of S100A2 by site-directed mutagenesis | Q33899997 | ||
| S100 proteins and their influence on pro-survival pathways in cancer | Q34337425 | ||
| A review of the S100 proteins in cancer | Q36848759 | ||
| Combining multiple serum biomarkers in tumor diagnosis: A clinical assessment | Q37641050 | ||
| S100 protein family in human cancer | Q37650123 | ||
| S100A2 in cancerogenesis: a friend or a foe? | Q37762477 | ||
| Cancer screening in the United States, 2011: A review of current American Cancer Society guidelines and issues in cancer screening | Q37826011 | ||
| Pathological diagnosis and classification of lung cancer in small biopsies and cytology: strategic management of tissue for molecular testing | Q37866183 | ||
| Classification of lung cancer | Q37897352 | ||
| Follow-up of patients with resected thoracic malignancies | Q37959768 | ||
| S100A4 calcium-binding protein is key player in tumor progression and metastasis: preclinical and clinical evidence | Q37959812 | ||
| New pathologic classification of lung cancer: relevance for clinical practice and clinical trials | Q38080823 | ||
| The clonal evolution and therapeutic approaches of lung cancer | Q38196755 | ||
| Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer | Q38289312 | ||
| Protumorigenic actions of S100A2 involve regulation of PI3/Akt signaling and functional interaction with Smad3. | Q39101381 | ||
| S100A6 binds p53 and affects its activity | Q39944401 | ||
| The role of S100A6 in pancreatic cancer development and its clinical implication as a diagnostic marker and therapeutic target. | Q40352989 | ||
| The role of S100 genes in breast cancer progression | Q42481244 | ||
| S100A2 induces metastasis in non-small cell lung cancer | Q45398473 | ||
| Increased cytoplasmic S100A6 expression is associated with pulmonary adenocarcinoma progression. | Q53374970 | ||
| Increased expression of S100A6 is associated with decreased metastasis and inhibition of cell migration and anchorage independent growth in human osteosarcoma. | Q53657596 | ||
| Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis. | Q54446617 | ||
| Genes encoding structural proteins of epidermal cornification and S100 calcium-binding proteins form a gene complex ("epidermal differentiation complex") on human chromosome 1q21 | Q71049670 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 2299-2304 | |
| P577 | publication date | 2015-09-11 | |
| P1433 | published in | Tumor Biology | Q15757842 |
| P1476 | title | Diagnostic significance of S100A2 and S100A6 levels in sera of patients with non-small cell lung cancer. | |
| P478 | volume | 37 |
| Q40912245 | Elevated serum apolipoprotein E is associated with metastasis and poor prognosis of non-small cell lung cancer |
| Q44892815 | High Expression of S100A6 Predicts Unfavorable Prognosis of Lung Squamous Cell Cancer |
| Q37184578 | Predicting Diagnostic Gene Biomarkers for Non-Small-Cell Lung Cancer |
| Q92996374 | Quantification of Calcyclin and Heat Shock Protein 90 in Sera from Women with and without Preeclampsia by Mass Spectrometry |
| Q39247295 | S100A6 protein: functional roles |
| Q93187344 | S100A6/miR193a regulates the proliferation, invasion, migration and angiogenesis of lung cancer cells through the P53 acetylation |
| Q37314018 | Serum levels of S100A6 are unaltered in patients with resectable cholangiocarcinoma |
| Q55282703 | The p53-S100A2 Positive Feedback Loop Negatively Regulates Epithelialization in Cutaneous Wound Healing. |
| Q38777795 | Tumor-derived factors modulating dendritic cell function |
Search more.